Public data Prescription dashboards and reports

Add more than one keyword by using commas. For example: prescribing, diabetes, health.

Searched keywords

A

Back to top

C

  • CD Comparators - Schedule 2 items (Excluding Methadone) (CD5)

    The Controlled Drugs Comparators Dashboard in ePACT2 helps ICBs and local health economies benchmark prescribing of controlled drugs against national and regional averages, identify outliers, and review compliance with safety standards.

  • CD Comparators - Schedule 3 items (CD6)

    The Controlled Drugs Comparators Dashboard in ePACT2 helps ICBs and local health economies benchmark prescribing of controlled drugs against national and regional averages.

  • CD Comparators - Total Items (CD3)

    This dashboard lets ICBs and local health economies compare controlled drug prescribing across England, showing variation and outliers. It supports safe prescribing by showing controlled drug use compared to overall prescribing, helping spot areas needing review.

  • CD Comparators Schedule 2 Items (CD4)

    Monitors prescribing of controlled drugs (Schedule 2-5) across practices and organisations. Helps identify unusual prescribing patterns to support controlled substances governance.

  • Common Information - CI2. Items and Fees Dispensed

    This report provides a rolling monthly summary of items dispensed and professional fees paid, supporting monitoring of dispensing activity across practices and ICBs. It strengthens financial governance by improving transparency, enabling validation of payments, and helping identify trends and variances in dispensing costs.

  • Common Information - CI1. Practice Items

    This report provides a detailed item‑level view of all prescriptions issued by a practice and processed by NHS Prescription Services. It supports transparency, benchmarking and medicines optimisation by helping practices monitor prescribing patterns, costs and alignment with best practice.

  • Cost Comparators - NIC/ADQ

    This report compares prescribing cost (NIC) against Average Daily Quantity (ADQ), enabling fair assessment of cost efficiency relative to prescribing volume and dose. It supports value-based prescribing by highlighting variation, benchmarking performance, and identifying opportunities to optimise costs without compromising patient care.

  • Cost Comparators - NIC/ASTRO PU (Standardised)

    This report compares prescribing costs using NIC adjusted for population demographics through ASTRO‑PUs, enabling fair comparison across organisations. It aids medicine optimisation and equitable resource allocation by showing unwarranted variation and guiding talks on prescribing efficiency and cost.

  • Cost Comparators - NIC/Item

    This report compares Net Ingredient Cost per item across organisations, highlighting variation in average prescribing costs at practice, SICBL and national level. It enables cost-effective prescribing by spotting outliers and savings opportunities, ensuring choices follow clinical guidance and patient outcomes.

Back to top

E

  • EPS and eRD Utilisation

    These dashboards provide insight into the use of the Electronic Prescription Service (EPS) and electronic Repeat Dispensing (eRD) across practices, PCNs and ICBs. They support monitoring of variation and trends, helping organisations prioritise local action and drive increased adoption of EPS and eRD to realise benefits for patients and the NHS.

Back to top

M

  • MO KTT - ADQ/Items

    The MO KTT ADQ/Items dashboard offers a summary of NHS community prescribing by organisation, allowing comparisons within a quarter, between quarters, or across years. It supports analysis of practice‑linked FP10 prescribing in England, while clearly defining inclusions and exclusions to ensure accurate interpretation of prescribing trends.

  • MO KTT - ADQ/STAR PU

    The MO KTT ADQ/Star PU dashboard offers a high-level view of NHS community prescribing across organisations, with comparisons within and across quarters or years. It supports analysis of practice‑linked FP10 prescribing in England, helping users understand prescribing patterns and trends while clearly defining data coverage and limitations.

  • MO KTT - Items/STAR PU

    The MO KTT Items/Star PU dashboard shows NHS community prescribing costs per weighted population at various organisational levels, with comparisons within the quarter, quarter-on-quarter, and year-on-year. It supports consistent benchmarking and trend analysis of practice-linked FP10 prescribing in England, with clearly defined inclusions and exclusions for accurate interpretation.

  • MO KTT - Percentage/Items

    The MO KTT Items/Items dashboard offers a high-level summary of NHS community prescribing across organisations, showing in-quarter, quarter-on-quarter, and year-on-year data. It supports consistent analysis of practice‑linked FP10 prescribing in England, enabling users to understand prescribing volume trends within clearly defined data boundaries.

Back to top

P

  • Potential Generic Savings

    The Potential Generic Savings report highlights where switching from branded to generic prescribing could release cost savings across NHS organisations. It provides a cost-based starting point for identifying savings opportunities, supporting medicines optimisation while stressing the need for clinical judgement before making changes.

  • Prescribing Monitoring - Out of Hours Care

    Monitors prescribing in out-of-hours care settings for quality and safety. Helps commissioners oversee unscheduled care prescribing practices.

  • Prescribing Monitoring - Repeat Dispensing Cost

    The Repeat Dispensing Cost Report provides insights into the financial impact of repeat dispensing arrangements, enabling practices and commissioners to monitor and analyse expenditure on repeat dispensing items.

  • Prescribing Monitoring - Repeat Dispensing Items

    The Repeat Dispensing Items Report in ePACT2 provides insights into prescriptions processed by NHS Prescription Services, offering visibility into utilisation patterns across practices and SICBLs.

  • Prescribing Monitoring Document

    Prescribing Monitoring Document provides monthly financial information about prescribing costs against budgets. This allows the drugs element of unified budgets to be managed.

  • Programme Budget Categories (PB2)

    The Programme Budget Categories (PB2) is a national programme budget project to map £50bn of NHS expenditure into 23 programmes of care, providing a primary source of information for better understanding of NHS expenditure.

Back to top

R

  • Reference - RF1. Patient List Sizes

    The RF1 Patient List Sizes Report provides monthly data on patient counts by practice, SICBL, and ICB, supporting fair comparisons of prescribing activity and cost.

  • Reference - RF2. Practice List Size and GP Count

    An extended reference report with additional practice list size breakdowns. Provides supplementary organisational data for prescribing analysis.

  • Reference - RF3. PCO List Size and GP Count

    A monthly report showing patient list size for each primary care organisation, split between prescribing and dispensing patients with practice and GP counts.

  • Respiratory

    Respiratory prescribing dashboard to improve health outcomes for patients with respiratory conditions by highlighting variation in prescribing across England.

  • Respiratory - Carbon Impact Dashboard

    Monitors inhaler prescribing and its carbon impact, supporting the NHS net-zero ambition to reduce greenhouse gas emissions from inhalers by 4% by 2040. Shows data on DPI vs MDI prescribing, lower-carbon salbutamol usage and high-carbon preventer inhalers at practice, PCN and sub-ICB levels.

Back to top

S

  • Specialist Drugs

    Provides insights into prescribing patterns and costs for specialist drugs, including those excluded from the national tariff. Enables users to monitor usage at SICBL, ICB and practice levels to validate claims and ensure compliance with commissioning agreements.

Back to top

V

  • Valproate Prescribing in Female Patients Under 55

    Tracks prescribing indicators for valproate medicines among women and girls of childbearing potential (ages 0–54). Supports the national effort to reduce valproate use in this population due to risks of birth defects and neurodevelopmental disorders in pregnancy.

  • Volume Comparators - ADQ/STAR PU

    The ADQ/STAR PU report provides a standardized measure of prescribing volume, adjusting for age and sex differences, to promote rational prescribing and identify opportunities for improvement.

  • Volume Comparators - Items/STAR PU

    The Items/STAR PU report in ePACT2 provides a demographic-adjusted view of prescribing volume by comparing the number of items prescribed per Specific Therapeutic Group Age-Sex Related Prescribing Unit (STAR PU), enabling fair comparison of activities and helping to identify unwarranted variation.

  • Volume Comparators - Minocycline ADQ/1000 Patients

    See prescribing of Minocycline Hydrochloride, measured as Average Daily Quantities (ADQs) per 1,000 registered patients.

  • Volume Comparators - Percentage Generic Items

    This report shows generic item-level prescribing data, presented quarterly and year-on-year (YoY).

Back to top